Familial cancer variant prioritization pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family
Whole-genome sequencing methods in familial cancer are useful to unravel rare clinically important cancer predisposing variants. Here, we present improvements in our pedigree-based familial cancer variant prioritization pipeline referred as FCVPPv2, including 12 tools for evaluating deleteriousness...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
02 August 2018
|
| In: |
Scientific reports
Year: 2018, Jahrgang: 8 |
| ISSN: | 2045-2322 |
| DOI: | 10.1038/s41598-018-29952-z |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1038/s41598-018-29952-z Verlag: https://www.nature.com/articles/s41598-018-29952-z 
|
| Verfasserangaben: | Abhishek Kumar, Obul Reddy Bandapalli, Nagarajan Paramasivam, Sara Giangiobbe, Chiara Diquigiovanni, Elena Bonora, Roland Eils, Matthias Schlesner, Kari Hemminki & Asta Försti |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1681856344 | ||
| 003 | DE-627 | ||
| 005 | 20220817024057.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191114s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41598-018-29952-z |2 doi | |
| 035 | |a (DE-627)1681856344 | ||
| 035 | |a (DE-599)KXP1681856344 | ||
| 035 | |a (OCoLC)1341250770 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kumar, Abhishek |e VerfasserIn |0 (DE-588)1050021142 |0 (DE-627)783151233 |0 (DE-576)404287565 |4 aut | |
| 245 | 1 | 0 | |a Familial cancer variant prioritization pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family |c Abhishek Kumar, Obul Reddy Bandapalli, Nagarajan Paramasivam, Sara Giangiobbe, Chiara Diquigiovanni, Elena Bonora, Roland Eils, Matthias Schlesner, Kari Hemminki & Asta Försti |
| 264 | 1 | |c 02 August 2018 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 14.11.2019 | ||
| 520 | |a Whole-genome sequencing methods in familial cancer are useful to unravel rare clinically important cancer predisposing variants. Here, we present improvements in our pedigree-based familial cancer variant prioritization pipeline referred as FCVPPv2, including 12 tools for evaluating deleteriousness and 5 intolerance scores for missense variants. This pipeline is also capable of assessing non-coding regions by combining FANTOM5 data with sets of tools like Bedtools, ChromHMM, Miranda, SNPnexus and Targetscan. We tested this pipeline in a family with history of a papillary thyroid cancer. Only one variant causing an amino acid change G573R (dbSNP ID rs145736623, NM_019609.4:exon11:c.G1717A:p.G573R) in the carboxypeptidase gene CPXM1 survived our pipeline. This variant is located in a highly conserved region across vertebrates in the peptidase_M14 domain (Pfam ID PF00246). The CPXM1 gene may be involved in adipogenesis and extracellular matrix remodelling and it has been suggested to be a tumour suppressor in breast cancer. However, the presence of the variant in the ExAC database suggests it to be a rare polymorphism or a low-penetrance risk allele. Overall, our pipeline is a comprehensive approach for prediction of predisposing variants for high-risk cancer families, for which a functional characterization is a crucial step to confirm their role in cancer predisposition. | ||
| 700 | 1 | |a Bandapalli, Obul Reddy |d 1977- |e VerfasserIn |0 (DE-588)13397121X |0 (DE-627)559235070 |0 (DE-576)30022544X |4 aut | |
| 700 | 1 | |a Paramasivam, Nagarajan |d 1985- |e VerfasserIn |0 (DE-588)1027462979 |0 (DE-627)729165485 |0 (DE-576)373239238 |4 aut | |
| 700 | 1 | |a Giangiobbe, Sara |e VerfasserIn |4 aut | |
| 700 | 1 | |a Diquigiovanni, Chiara |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bonora, Elena |e VerfasserIn |4 aut | |
| 700 | 1 | |a Eils, Roland |d 1965- |e VerfasserIn |0 (DE-588)1020648287 |0 (DE-627)691291705 |0 (DE-576)361718195 |4 aut | |
| 700 | 1 | |a Schlesner, Matthias |d 1978- |e VerfasserIn |0 (DE-588)138455201 |0 (DE-627)602593867 |0 (DE-576)307654656 |4 aut | |
| 700 | 1 | |a Hemminki, Kari |d 1947- |e VerfasserIn |0 (DE-588)1150735872 |0 (DE-627)1010964402 |0 (DE-576)172043751 |4 aut | |
| 700 | 1 | |a Försti, Asta |e VerfasserIn |0 (DE-588)1155331672 |0 (DE-627)1017045755 |0 (DE-576)501623833 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Scientific reports |d [London] : Springer Nature, 2011 |g 8(2018) Artikel-Nummer 11635, 12 Seiten |h Online-Ressource |w (DE-627)663366712 |w (DE-600)2615211-3 |w (DE-576)346641179 |x 2045-2322 |7 nnas |a Familial cancer variant prioritization pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family |
| 773 | 1 | 8 | |g volume:8 |g year:2018 |g extent:12 |a Familial cancer variant prioritization pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41598-018-29952-z |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41598-018-29952-z |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20191114 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 1155331672 |a Försti, Asta |m 1155331672:Försti, Asta |d 50000 |e 50000PF1155331672 |k 0/50000/ |p 10 |y j | ||
| 998 | |g 1150735872 |a Hemminki, Kari |m 1150735872:Hemminki, Kari |d 50000 |e 50000PH1150735872 |k 0/50000/ |p 9 | ||
| 998 | |g 138455201 |a Schlesner, Matthias |m 138455201:Schlesner, Matthias |d 140000 |e 140000PS138455201 |k 0/140000/ |p 8 | ||
| 998 | |g 1020648287 |a Eils, Roland |m 1020648287:Eils, Roland |d 910000 |d 999701 |e 910000PE1020648287 |e 999701PE1020648287 |k 0/910000/ |k 1/910000/999701/ |p 7 | ||
| 998 | |g 1027462979 |a Paramasivam, Nagarajan |m 1027462979:Paramasivam, Nagarajan |d 50000 |e 50000PP1027462979 |k 0/50000/ |p 3 | ||
| 998 | |g 13397121X |a Bandapalli, Obul Reddy |m 13397121X:Bandapalli, Obul Reddy |d 50000 |e 50000PB13397121X |k 0/50000/ |p 2 | ||
| 999 | |a KXP-PPN1681856344 |e 3540154507 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"12 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1681856344"],"doi":["10.1038/s41598-018-29952-z"]},"relHost":[{"pubHistory":["1, article number 1 (2011)-"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"recId":"663366712","disp":"Familial cancer variant prioritization pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer familyScientific reports","note":["Gesehen am 12.07.24"],"id":{"eki":["663366712"],"zdb":["2615211-3"],"issn":["2045-2322"]},"part":{"text":"8(2018) Artikel-Nummer 11635, 12 Seiten","volume":"8","year":"2018","extent":"12"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Scientific reports","title":"Scientific reports"}],"origin":[{"dateIssuedKey":"2011","publisherPlace":"[London] ; London","publisher":"Springer Nature ; Nature Publishing Group","dateIssuedDisp":"2011-"}]}],"note":["Gesehen am 14.11.2019"],"person":[{"role":"aut","family":"Kumar","given":"Abhishek","display":"Kumar, Abhishek"},{"family":"Bandapalli","given":"Obul Reddy","display":"Bandapalli, Obul Reddy","role":"aut"},{"display":"Paramasivam, Nagarajan","given":"Nagarajan","family":"Paramasivam","role":"aut"},{"role":"aut","given":"Sara","display":"Giangiobbe, Sara","family":"Giangiobbe"},{"display":"Diquigiovanni, Chiara","given":"Chiara","family":"Diquigiovanni","role":"aut"},{"family":"Bonora","given":"Elena","display":"Bonora, Elena","role":"aut"},{"role":"aut","family":"Eils","given":"Roland","display":"Eils, Roland"},{"family":"Schlesner","display":"Schlesner, Matthias","given":"Matthias","role":"aut"},{"role":"aut","display":"Hemminki, Kari","given":"Kari","family":"Hemminki"},{"role":"aut","display":"Försti, Asta","given":"Asta","family":"Försti"}],"recId":"1681856344","name":{"displayForm":["Abhishek Kumar, Obul Reddy Bandapalli, Nagarajan Paramasivam, Sara Giangiobbe, Chiara Diquigiovanni, Elena Bonora, Roland Eils, Matthias Schlesner, Kari Hemminki & Asta Försti"]},"origin":[{"dateIssuedDisp":"02 August 2018","dateIssuedKey":"2018"}],"language":["eng"],"title":[{"title_sort":"Familial cancer variant prioritization pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family","title":"Familial cancer variant prioritization pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family"}]} | ||
| SRT | |a KUMARABHISFAMILIALCA0220 | ||